Advertisement

Topics

Latest "Incorporated" News Stories

20:23 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Incorporated" found in our extensive news archives from over 250 global news sources.

More Information about Incorporated on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Incorporated for you to read. Along with our medical data and news we also list Incorporated Clinical Trials, which are updated daily. BioPortfolio also has a large database of Incorporated Companies for you to search.

Showing "Incorporated" News Articles 1–25 of 28

Relevant

CERESPIR INCORPORATED and the NATIONAL NEUROSCIENCE INSTITUTE SINGAPORE Announce Positive Data Showing Beneficial Effects of CERESPIR’s Clinical Stage Compound Itanapraced in a LRRK2 Model of Parkinson’s Disease 

Itanapraced blocks LRRK2 expression and LRRK2-mediated neurotoxicity Itanapraced ready to advance to Phase 2 in Parkinson’s disease patients with and without genetic mutation NEW YORK and SINGAPORE, Dec. 10, 2018 (GLOBE NEWSWIRE) -- CERESPIR INCORPORATED a pharmaceutical company engaged in the discovery and development of disease-modifying therapeutics for the treatment of neurodegenerative...


Probably Relevant

Global Fire Protection Materials Market Status and Outlook 20182025 [Report Updated: 19082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Arcis Biotechnology and Teleflex sign license agreement

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology Daresbury, UK, 16 October 2018: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis&rs...


Possibly Relevant

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis

Novartis International AG / Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office  The listed ...

Global Bioactive Ingredients Market Growth, Trend and Forecast 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The market was valued is expected to reach over USD 43.25 million by 2023, projecting a healthy CAGR of 6.3% over the forecast period, 20182023. The market has growing extensively due to the increasing global consumption of dietary supplements. Bioactive ingredients are necessary constituents found in most dietary supplements which help in improving the health of consumers. Market DynamicsBioactiv...

Expedeon AG signs supply and license agreement with Quanterix Corporation for access to proprietary immunoassay technology

Expedeon’s proprietary immunoassay technology to be incorporated into Quanterix’ Simoa Planar Immunoassay products Heidelberg, Germany and Cambridge, UK, 07 November 2018 – Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today announced a supply and license agreement with United States based Life Sciences company, Quanterix Corporation. The agreement provi...

University of Houston chooses JEOL for its growing NMR needs

7th September 2018: The University of Houston has added two new JEOL NMR systems to its existing suite as demand for NMR spectroscopy among students and researchers grows. The University of Houston’s chemistry department now has four NMR systems and the pharmacy department has one – all from JEOL Inc. Users come from a range of disciplines, with biology, physics and engineering ...

Redx Pharma Plc REDX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

Summary   Redx is a UK biotechnology company and drug development company focused on cancer and fibrosis. Its shares are traded on AIM (AIM:REDX). Redx’s vision is to become a leading biotech focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases.   Redx Pharma Plc REDX Pharmaceuticals Healt...

A new tool from JEOL for structural analysis of pharmaceutical mixtures

17 January 2019, PEABODY: JEOL USA has developed new methodology using the company’s ROYAL HFX Probe to offer a powerful and practical alternative for the elucidation of crucial structural information. It has particular merit in the analysis of complex pharmaceutical mixtures that contain a drug substance plus its various metabolites. It’s a familiar challenge for pharmaceutical...

Global Next Generation Sequencing Informatics Market Segmented by Services Type, Applications and End Users Growth, Trends and Forecasts 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global next generation sequencing informatics market is expected to register a CAGR of about 22.0% during 20182023 the forecast period. North America is dominating the market, due to the growing demand for NGS informatics product services in the region.Growing Demand for NGS Service and Rising Investment by Key PlayersThe next generation sequencing NGS informatics services have gained popula...

Global Sorbitol Market Segmented by Form, Function, Application and Geography 2018 2023 [Report Updated: 08022018] Prices from USD $4250

Merck one of the leading sorbitol manufactures developed directly compressible sorbitol Parteck SI . The unique particle structure of Parteck SI gives it distinctive physical properties, making it the perfect excipient for combining many ingredients into one elegant and robust tablet formulation. The market was is expected to reach USD 1.28 billion by 2023, registering a CAGR of 5.5%, during 20182...

BioDuro LLC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

Summary 2015 - BioDuro is reacquired from PPD. BioDuro and Formex merge to enable service offerings that span from API synthesis to formulation development and cGMP manufacture of drug product. BioDuro LLC BioDuro, a subsidiary of Pharmaceutical Product Development LLC is a discoverer and developer of small molecule and biologics. The institute offers discovery, development and manufacturing...

Redx Pharma Plc REDX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

Summary   Redx Pharma Plc Redx Pharma, formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. Redx Pharma uses its proven drug discovery expertise to generate development candidates that it will take into the clinic and then partner. The company’s product development strategy has three interrelated componen...

Global Food Starch Market Growth, Trend and Forecast 2018 2023 [Report Updated: 01032018] Prices from USD $4250

The global starch market is poised to register a CAGR of 5.85%.The market is competitive and driven by an increase in the trend of health and wellness and growing consumer demand for all natural ingredients. Cereals, particularly breads and breakfast cereals, and potatoes make the major contribution to starch intakes in the western diets. Starch intakes are considerably higher in countries depende...

Teleflex Acquires Essential Medical

Acquisition expands presence in structural heart and endovascular aneurysm repair markets by adding unique large bore closure system Teleflex Incorporated (NYSE: TFX) today announced that it has acquired Essential Medical, Inc. Based in Exton, PA, Essential Medical is a privately-held medical device company that has developed and commercialized the CE ...

Mannatech Reports Third Quarter 2018 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2018. Third Quarter Results Third quarter net

Mannatech Reports Second Quarter 2018 Financial Results

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2018. Second Quarter Results Second quarter net

Global Alcoholic Drinks Packaging Market Segmented By Material Plastic, Paper, Metal, Glass, Products Type Bottles, Metal Cans, Cartons, Pouches, Products Beer, Spirits, Wine, Ready to Drink and Region Growth, Trends and Forecasts 2018 2023 [Report Upd

The global alcoholic drinks packaging market was valued at USD 27.06 billion in 2017 and is expected to reach a market value of USD 36.38 billion by 2023, registering a CAGR of 5.06% during 2018 2023. Alcoholic drinks consumption is expected to increase in the forecast period, directly influencing the alcoholic drinks packaging market. The type of products considered under the scope of study are ...

Akebia Therapeutics Appoints Cynthia Smith to Its Board of Directors

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), today announced the appointment of Cynthia Smith to its Board of Directors. “Cynthia is an accomplished leader with an impressive background in the...

Teleflex Reports Third Quarter 2018 Results

Third Quarter Revenues of $609.7 million, up 14.0% Versus Prior Year Period; up 15.0% on Constant Currency Basis Third Quarter GAAP Diluted EPS of $1.21, down 28.8% Over the Prior Year Period Third Quarter Adjusted Diluted EPS of $2.52, up 18.9% Versus Prior Year Period Lowered 2018 Guidance Range for GAAP Revenue Growth f...

Probiodrug AG Reports Third Quarter 2018 Business Update

Probiodrug / Probiodrug AG Reports Third Quarter 2018 Business Update . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Probiodrug AG Reports Third Quarter 2018 Business Update HALLE (SAALE), Germany, 29 November 2018 - Probiodrug AG (Euronext Amsterdam: PBD), a clinical stage biopharmaceutical company d...

Sparton Corporation to Be Acquired by Cerberus

Transaction Provides a Significant Premium to Shareholders and a Strong Partner to Support Future Growth Sparton Corporation (“Sparton” or the “Company”) (NYSE:SPA) today announced that it has entered into a definitive agreement to be acquired by an affiliate of Cerberus Capital Management, L.P. (“Cerberus”), a global leader in alternative ...

Ligand Reports Third Quarter 2018 Financial Results

Raises 2018 Financial Guidance Conference Call Begins at 9:00 a.m. Eastern Time Today Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2018, and provided an operating forecast and program updates. Ligand management will host a conference call today b...

Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending Akebia Shareholders Vote “FOR” Proposed Merger with Keryx

Akebia Urges Shareholders to Vote “FOR” the Merger-Related Shareholder Proposals Today Akebia Therapeutics, Inc. (Nasdaq:AKBA) (“Akebia” or the “Company”) today announced that leading independent proxy advisory firm, Glass Lewis & Co. (“Glass Lewis”), joins Institutional Shareholder Services (“ISS”) in recommending that Akebia s...

Akebia Therapeutics Sends Letter to Shareholders

Recommends Shareholders Vote “FOR” the Proposals Relating to the Merger Akebia Therapeutics, Inc. (Nasdaq: AKBA) mailed a letter to Akebia shareholders in connection with the special meeting of Akebia shareholders (the “Special Meeting”) that has been called to approve shareholder proposals relating to the previously announced proposed m...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks